Secondary surfactant deficiencies;Les déficits secondaires en surfactant

Archives de Pediatrie

Volumn 11, Issue 11, 2004, Pages 1351-1359

  Escande, B ^a   Kuhn, P ^a   Rivera, S ^a   Messer, J ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Bronchiolite; Hernie diaphragmatique cong nitale; Infant, newborn; Inhalation m coniale; Meconium aspiration; Nouveau n ; Pulmonary surfactants, deficiency; Respiratory distress syndrome, adult; SDRA; Surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; CALFACTANT; LUCINACTANT; LUNG SURFACTANT; LUSUPULTIDE; PORACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B;

BRONCHIOLITIS; CARBON DIOXIDE TENSION; CHILD; DIAPHRAGM HERNIA; EXTRACORPOREAL OXYGENATION; HUMAN; HYALINE MEMBRANE DISEASE; HYPOXIA; LUNG ALVEOLUS CELL TYPE 2; LUNG DISEASE; LUNG DYSPLASIA; LUNG HEMORRHAGE; LUNG INFECTION; LUNG INJURY; LUNG LAVAGE; LUNG SURFACTANT DEFICIENCY; MECONIUM ASPIRATION; PNEUMONIA; PREMATURITY; RESPIRATORY DISTRESS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SEPSIS;

EID: 7444232234     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.05.021     Document Type: Short Survey

References (68)

1. Suresh G.K., Soll R.K. Current surfactant use in premature infants. Clin perinatol. 28:2001;671-694
2. Nogee L.M., de Mello D.E., Dehner L.P., Colten H.R. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med. 328:1993;406-410
3. Nogee L.M., Dunbar A.E. 3rd, Wert S.E., Askin F., Hamvas A., Whitsett J.A. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med. 344:2001;573-579
4. Jobe A.H., Ikegami M. Surfactant metabolism. Clin Perinatol. 20:1993;683-696
5. Brown D., Pattishall E.N. Other uses of surfactant. Clin Perinatol. 20:1993;761-789
6. Walti H. Bases de l'utilisation thérapeutique des surfactants exogènes dans les déficiences secondaires en surfactant. Mt pédiatr. 2:1999;15-22. hors série, mars-avril
7. Holm B.A. Surfactant inactivation in adult respiratory distress syndrome. Robertson B., Van Golde L., Batenburg J. Pulmonary surfactant: from molecular biology to clinical practice. 1992;665-684 Elsevier, Amsterdam
8. Sun B., Curstedt T., Robertson B. Surfactant inhibition in experimental meconium aspiration. Acta Paediatr. 82:1993;182-189
9. Sun B., Curstedt T., Song G.W., Robertson B. Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol Neonate. 63:1993;96-104
10. Oh M.H., Bae C.W. Inhibitory effect of meconium on pulmonary surfactant function tested in vitro using the stable micro-bubble test. Eur J Pediatr. 159:2000;770-774
11. Findlay R.D., Taeusch H.W., Walther F.J. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics. 97:1996;48-52
12. Lotze A., Mitchell B.R., Bulas D.I., Zola E.M., Shalwitz R.A., Gunkel J.H. Survanta in term infants study group. Multicenter study of surfactant (Beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr. 132:1998;40-47
13. Paranka H.S., Walsh W.F., Stancombe B.B. Surfactant lavage in a piglet model of meconium aspiration syndrome. Pediatr Res. 31:1992;625-628
14. Lam B.C., Yeung C.Y. Surfactant lavage for meconium aspiration syndrome: a pilot study. Pediatrics. 103:1999;1014-1018
15. Herting E., Rauprich P., Stichtenoth G., Walter G., Johansson J., Robertson B. Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res. 50:2001;44-49
16. Wiswell T.E., Knight G.R., Finer N.N., Donn S.M., Desai H., Walsh W.F., et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics. 109:2002;1081-1087
17. Kattwinkel J. Surfactant lavage for meconium aspiration: a word of caution. Pediatrics. 109:2002;1167-1168
18. ®. Pediatr Res. 53:2003;435 A
19. Ueda T., Ikegami M., Jobe A. Surfactant subtypes. In vitro conversion, in vivo function, and effects of serum proteins. Am J Respir Crit Care Med. 149:1994;1254-1259
20. Bui K.C., Walther F.J., David-Cu R., Garg M., Warburton D. Phospholipid and surfactant protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation. J Pediatr. 121:1992;271-274
21. Jackson J.C., Truog W.E., Standaert T.A., Murphy J.H., Juul S.E., Chi E.Y., et al. Reduction in lung injury after combined surfactant and high-frequency ventilation. Am J Respir Crit Care Med. 150:1994;534-539
22. Khammash H., Perlman M., Wojtulewicz J., Dunn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics. 92:1993;135-139
23. Lotze A., Knight G.R., Martin G.R., Bulas D.I., Hull W.M., O'Donnell R.M., et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr. 122:1993;261-268
24. Micheli J.L., Tolsa J.F. Œdème pulmonaire : de la détresse respiratoire transitoire à l'hémorragie alvéolaire. Dehan M., Micheli J.L. Le poumon du nouveau-né 2000;123-132 Doin, Paris
25. James D.K., Chiswick M.L., Harks A., Williams M., Hallworth J. Non-specificity of surfactant deficiency in neonatal respiratory disorders. BMJ (Clin Res Ed). 288:1984;1635-1638
26. Bourbon J.R., Francoual J., Magny J.F., Lindenbaum A., Leluc R., Dehan M. Changes in phospholipids composition of tracheal aspirates from newborns with hyaline membrane disease or transient tachypnea. Clin Chim Acta. 189:1990;87-94
27. Suen H.C., Catlin E.A., Ryan D.P., Wain J.C., Donahoe P.K. Biochemical immaturity of lungs in congenital diaphragmatic hernia. J Pediatr Surg. 28:1993;471-477
28. Moya F.R., Thomas V.L., Romaguera J., Mysore M.R., Maberry M., Bernard A., et al. Fetal lung maturation in congenital diaphragmatic hernia. Am J Obstet Gynecol. 173:1995;1401-1405
29. Cogo P.E., Zimmermann L.J.I., Meneghini L., Mainini N., Bordignon L., Suma V., et al. Pulmonary surfactant disaturated phosphatidylcholine (DSPC) turn over and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res. 54:2003;653-658
30. Ijsselstijn H., Zimmermann L., Bunt J., de Jongste J., Tibboel D. Prospective evaluation of surfactant composition in bronchoalveolar lavage fluid of infants with congenital diaphragmatic hernia and of age-matched controls. Crit Care Med. 26:1998;573-580
31. Ijsselstijn H., Tibboel D. The lungs in congenital diaphragmatic hernia: do we understand? Pediatr Pulmonol. 26:1998;204-218
32. O'Toole S.J., Karamanoukian H.L., Sharma A., Morin F.C. 3rd, Holm B.A., Azizkhan R.G., et al. Surfactant rescue in the fetal lamb model of congenital diaphragmatic hernia. J Pediatr Surg. 31:1996;1105-1109
33. Lotze A., Knight G.R., Anderson K.D., Hull W.M., Whitsett J.A., O'Donnell R.M., et al. Surfactant (Beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg. 29:1994;407-412
34. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N Engl J Med. 342:2000;1334-1339
35. Lachmann B., Van Daal G. Adult respiratory distress syndrome: animal models. Robertson B., Van Golde L., Batenburg J. Pulmonary surfactant: from molecular biology to clinical practice. 1992;635-663 Elsevier, Amsterdam
36. Gregory T.J., Longmore W.J., Moxley M.A., Whitsett J.A., Reed C.R., Fowler A.A., et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 88:1991;1976-1981
37. Anzueto A., Baughman R.P., Guntupalli K.K., Weg J.G., Wiedemann H.P., Raventos A.A., et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med. 334:1996;1417-1421
38. Gregory T.J., Steinberg K.P., Spragg R., Gadek J.E., Hyers T.M., Longmore W.J., et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 155:1997;1309-1315
39. Walmrath D.A., Gunther H.A., Ghofrani H.A., Schermuly R., Schneider T., Grimminger F., et al. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med. 154:1996;57-62
40. Marraro G.A., Luchetti M., Galassini E.M., Abbiati G. Natural surfactant supplementation in ARDS in paediatric age. Minerva Anestesiol. 65:(5 suppl 1):1999;92-97
41. Lopez-Herce J., de Lucas N., Carrillo A., Bustinza A., Moral R. Surfactant treatment for acute respiratory distress syndrome. Arch Dis Child. 80:1999;248-252
42. Willson D.F., Zaritsky A., Bauman L.A., Dockery K., James R.L., Conrad D., et al. Instillation of calf lung surfactant extract (Calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care med. 27:1999;188-195
43. Herting E., Moller O., Schiffmann J.H., Robertson B. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr. 91:2002;1174-1178
44. Dargaville P.A., South M., McDougall P.N. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child. 75:1996;133-136
45. Kerr M.H., Paton J.Y. Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med. 159:1999;1115-1118
46. Skelton R., Holland P., Darowski M., Chetcuti P.A., Morgan L.W., Harwood J.L. Abnormal surfactant composition and activity in severe bronchiolitis. Acta Paediatr. 88:1999;942-946
47. Luchetti M., Casiraghi G., Valsecchi R., Galassini E., Marraro G. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand. 42:1998;805-810
48. Tibby S.M., Hatherill M., Wright S.M., Wilson P., Postle A.D., Murdock I.A. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 162:2000;1251-1256
49. Haroon M. Can surfactant cure babies with severe bronchiolitis? Arch Dis Child. 88:2003;834-835
50. Raju T.N.K., Langerberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a meta analysis. J Pediatr. 123:1993;603-610
51. Amizuka T., Shimizu H., Niida Y., Ogawa Y. Surfactant therapy in neonates with respiratory failure due to hemorrhagic pulmonary edema. Eur J Pediatr. 162:2003;697-702
52. Pandit P.B., Dunn M.S., Colucci E.A. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics. 95:1995;32-36
53. Baughman R.P., Sternberg R.I., Hull W., Buchsbaum J.A., Whitsett J. Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis. 147:1993;653-657
54. Griese M., Dietrich P., Potz C., Westerburg B., Bals R., Reinhardt D. Surfactant subfractions during nosocomial infection in ventilated preterm human neonates. Am J Respir Crit Care Med. 153:1996;398-403
55. Herting E., Jarstrand C., Rasool O., Curstedt T., Sun B., Robertson B. Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res. 36:1994;784-791
56. Herting E., Gefeller O., Land M., van Sonderen L., Harms K., Robertson B. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics. 106:2000;957-964
57. Merrill J.D., Ballard R.A. Pulmonary surfactant for neonatal respiratory disorders. Curr Opin Pediatr. 15:2003;149-154
58. Coalson J.J., King R.J., Yang Y., Winter V., Whitsett J.A., Delemon R.A., et al. SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. Am J Respir Crit Care Med. 151:1995;854-866
59. Obladen M. Alterations in surfactant composition. Merritt A., Northway W.H., Boynton B.R. Bronchopulmonary dysplasia. 1988;131-141 Blackwell Scientific, Boston
60. Clement A., Masliah J., Housset B., Just J., Garcia J., Grimfeld A., et al. Decreased phosphatidylcholine content in bronchoalveolar lavage fluids of children with bronchopulmonary dysplasia: a preliminary investigation. Pediatr Pulmonol. 3:1987;67-70
61. Cogo P.E., Zimmermann J.L., Sachetto E., Badon T., Pianta T., Torresin M., et al. Surfactant half life (HL) in preterm infants with bronchopulmonary dysplaesia (BPD) using stable isotope labeled phosphatidylcholine. Pediatr Res. 47:2000;393 A
62. Merrill J.D., Ballard R.A., Godinez R.I., Godinez M.H., Ballard P.L. Surfactant function and composition in premature infants with lung disease. Pediatr Res. 51:2002;347 A
63. Beers M.F., Hamvas A., Moxley M.A., Gonzales L.W., Guttentag S.H., Solarin K.O., et al. Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am J Respir Cell Mol Biol. 22:2000;380-391
64. Kazzi S.N.J., Schurch S., McLaughlin K.L., Romero R., Janisse J. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia. Acta Paediatr. 89:2000;1218-1225
65. Ashton M.R., Postle A.D., Hall M.A., Smith S.L., Kelly F.J., Normand I.C.S. Phosphatidyl choline composition of endotracheal tube aspirates of neonates and subsequent respiratory disease. Arch Dis Child. 67:1992;378-382
66. Pandit P.B., Dunn M.S., Kelly E.N., Perlman M. Surfactant replacement in neonates with early chronic lung disease. Pediatrics. 95:1995;851-854
67. Merrill J.D., Ballard R.A., Godinez R.I., Godinez M.H., Cnaan A., Xianqun L., et al. Respiratory decompensation and surfactant dysfunction in preterm infants. Pediatr Res. 52:2003;404 A
68. Lacaze-Masmonteil T. Exogenous surfactant therapy: newer developments. Semin Neonatol. 8:2003;433-440